PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb13
|
ENSMUSG00000049604.4 | Hoxb13 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb13 | mm39_v1_chr11_+_96085118_96085142 | 0.33 | 5.2e-03 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_145946408 | 13.35 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr1_+_13738967 | 10.19 |
ENSMUST00000088542.4
|
Xkr9
|
X-linked Kx blood group related 9 |
chr8_+_21515561 | 10.14 |
ENSMUST00000076754.3
|
Defa21
|
defensin, alpha, 21 |
chr3_+_92123106 | 9.79 |
ENSMUST00000074449.7
ENSMUST00000090871.3 |
Sprr2a1
Sprr2a2
|
small proline-rich protein 2A1 small proline-rich protein 2A2 |
chr3_-_72875187 | 9.74 |
ENSMUST00000167334.8
|
Sis
|
sucrase isomaltase (alpha-glucosidase) |
chr6_+_78347636 | 8.40 |
ENSMUST00000204873.3
|
Reg3b
|
regenerating islet-derived 3 beta |
chr3_+_138019040 | 8.05 |
ENSMUST00000013455.13
ENSMUST00000106247.2 |
Adh6a
|
alcohol dehydrogenase 6A (class V) |
chr11_-_120954281 | 7.92 |
ENSMUST00000130786.2
ENSMUST00000168459.8 ENSMUST00000081499.9 ENSMUST00000039309.12 |
Sectm1b
|
secreted and transmembrane 1B |
chr17_-_34736326 | 7.84 |
ENSMUST00000075483.5
|
Btnl6
|
butyrophilin-like 6 |
chr8_+_22108199 | 7.65 |
ENSMUST00000074343.6
|
Defa26
|
defensin, alpha, 26 |
chr3_+_92158054 | 7.58 |
ENSMUST00000071805.4
|
Sprr2a2
|
small proline-rich protein 2A2 |
chr5_-_87686048 | 7.48 |
ENSMUST00000031199.11
|
Sult1b1
|
sulfotransferase family 1B, member 1 |
chr1_-_173105344 | 7.45 |
ENSMUST00000111224.5
|
Mptx2
|
mucosal pentraxin 2 |
chr11_-_99328969 | 6.78 |
ENSMUST00000017743.3
|
Krt20
|
keratin 20 |
chr17_-_31348576 | 6.76 |
ENSMUST00000024827.5
|
Tff3
|
trefoil factor 3, intestinal |
chr13_-_24098981 | 6.63 |
ENSMUST00000110407.4
|
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr3_-_144555062 | 6.52 |
ENSMUST00000159989.2
|
Clca3b
|
chloride channel accessory 3B |
chr13_-_24098951 | 6.44 |
ENSMUST00000021769.16
|
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr8_+_21739729 | 6.42 |
ENSMUST00000098895.3
|
Defa40
|
defensin, alpha, 40 |
chr3_-_144638284 | 6.33 |
ENSMUST00000098549.4
|
Clca4b
|
chloride channel accessory 4B |
chr8_+_21555054 | 6.23 |
ENSMUST00000078121.4
|
Defa35
|
defensin, alpha, 35 |
chr11_+_96085118 | 6.10 |
ENSMUST00000062709.4
|
Hoxb13
|
homeobox B13 |
chr19_-_11058452 | 5.97 |
ENSMUST00000025636.8
|
Ms4a8a
|
membrane-spanning 4-domains, subfamily A, member 8A |
chr5_+_146016064 | 5.87 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr3_-_144738526 | 5.81 |
ENSMUST00000029919.7
|
Clca1
|
chloride channel accessory 1 |
chr12_-_114487525 | 5.78 |
ENSMUST00000103495.3
|
Ighv10-3
|
immunoglobulin heavy variable V10-3 |
chr9_+_78164402 | 5.69 |
ENSMUST00000217203.2
|
Gm3776
|
predicted gene 3776 |
chr3_+_69129745 | 5.64 |
ENSMUST00000183126.2
|
Arl14
|
ADP-ribosylation factor-like 14 |
chr19_+_43770619 | 5.51 |
ENSMUST00000026208.6
|
Abcc2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
chr9_+_98372575 | 5.48 |
ENSMUST00000035029.3
|
Rbp2
|
retinol binding protein 2, cellular |
chr6_+_71176811 | 5.39 |
ENSMUST00000067492.8
|
Fabp1
|
fatty acid binding protein 1, liver |
chr17_-_34694911 | 5.38 |
ENSMUST00000065841.5
|
Btnl4
|
butyrophilin-like 4 |
chr5_-_87485023 | 5.25 |
ENSMUST00000031195.3
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr8_-_22193658 | 5.20 |
ENSMUST00000071886.7
|
Defa39
|
defensin, alpha, 39 |
chr11_+_115778427 | 5.18 |
ENSMUST00000167507.3
|
Myo15b
|
myosin XVB |
chr6_-_70051586 | 5.12 |
ENSMUST00000103377.3
|
Igkv6-32
|
immunoglobulin kappa variable 6-32 |
chr10_-_116732813 | 5.09 |
ENSMUST00000048229.9
|
Myrfl
|
myelin regulatory factor-like |
chr7_-_19410749 | 5.01 |
ENSMUST00000003074.16
|
Apoc2
|
apolipoprotein C-II |
chr4_+_11758147 | 4.93 |
ENSMUST00000029871.12
ENSMUST00000108303.2 |
Cdh17
|
cadherin 17 |
chr1_+_131566044 | 4.88 |
ENSMUST00000073350.13
|
Ctse
|
cathepsin E |
chr17_+_37209002 | 4.85 |
ENSMUST00000078438.5
|
Trim31
|
tripartite motif-containing 31 |
chr19_+_39049442 | 4.78 |
ENSMUST00000087236.5
|
Cyp2c65
|
cytochrome P450, family 2, subfamily c, polypeptide 65 |
chrX_+_100419965 | 4.76 |
ENSMUST00000119080.8
|
Gjb1
|
gap junction protein, beta 1 |
chr9_-_35010357 | 4.72 |
ENSMUST00000214526.2
ENSMUST00000217149.2 |
St3gal4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
chr10_+_116013122 | 4.66 |
ENSMUST00000148731.8
|
Ptprr
|
protein tyrosine phosphatase, receptor type, R |
chr11_-_11848107 | 4.65 |
ENSMUST00000178704.8
|
Ddc
|
dopa decarboxylase |
chr3_+_3699205 | 4.63 |
ENSMUST00000108394.3
|
Hnf4g
|
hepatocyte nuclear factor 4, gamma |
chr19_-_11209797 | 4.63 |
ENSMUST00000186228.3
|
Ms4a12
|
membrane-spanning 4-domains, subfamily A, member 12 |
chr10_+_5589210 | 4.42 |
ENSMUST00000019906.6
|
Vip
|
vasoactive intestinal polypeptide |
chr16_-_14109219 | 4.40 |
ENSMUST00000230397.2
ENSMUST00000231567.2 ENSMUST00000090287.5 |
Myh11
|
myosin, heavy polypeptide 11, smooth muscle |
chr2_-_122128930 | 4.31 |
ENSMUST00000237546.2
|
Duox2
|
dual oxidase 2 |
chr15_-_77283286 | 4.29 |
ENSMUST00000175919.8
ENSMUST00000176074.9 |
Apol7a
|
apolipoprotein L 7a |
chr2_+_14179324 | 4.25 |
ENSMUST00000077517.9
|
Tmem236
|
transmembrane protein 236 |
chr19_+_40078132 | 4.24 |
ENSMUST00000068094.13
ENSMUST00000080171.3 |
Cyp2c50
|
cytochrome P450, family 2, subfamily c, polypeptide 50 |
chr6_-_78445846 | 4.22 |
ENSMUST00000032089.3
|
Reg3g
|
regenerating islet-derived 3 gamma |
chr13_-_42001075 | 4.20 |
ENSMUST00000179758.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr12_-_115884332 | 4.19 |
ENSMUST00000103548.3
|
Ighv1-81
|
immunoglobulin heavy variable 1-81 |
chr12_+_31440842 | 4.14 |
ENSMUST00000167432.8
|
Slc26a3
|
solute carrier family 26, member 3 |
chr17_+_31652073 | 4.13 |
ENSMUST00000237363.2
|
Pde9a
|
phosphodiesterase 9A |
chr3_-_98660781 | 4.09 |
ENSMUST00000094050.11
ENSMUST00000090743.13 |
Hsd3b3
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
chr18_-_61169262 | 4.08 |
ENSMUST00000025521.9
|
Cdx1
|
caudal type homeobox 1 |
chr6_-_115569504 | 4.07 |
ENSMUST00000112957.2
|
Mkrn2os
|
makorin, ring finger protein 2, opposite strand |
chr17_+_31652029 | 4.04 |
ENSMUST00000136384.9
|
Pde9a
|
phosphodiesterase 9A |
chr1_+_88022776 | 4.02 |
ENSMUST00000150634.8
ENSMUST00000058237.14 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr3_-_144680801 | 4.02 |
ENSMUST00000029923.10
ENSMUST00000238960.2 |
Clca4a
|
chloride channel accessory 4A |
chr17_+_87943401 | 4.00 |
ENSMUST00000235125.2
ENSMUST00000053577.9 ENSMUST00000234009.2 |
Epcam
|
epithelial cell adhesion molecule |
chr8_+_21691577 | 4.00 |
ENSMUST00000110754.2
|
Defa41
|
defensin, alpha, 41 |
chr12_-_113802603 | 3.99 |
ENSMUST00000103458.3
ENSMUST00000193652.2 |
Ighv5-16
|
immunoglobulin heavy variable 5-16 |
chr19_+_38995463 | 3.96 |
ENSMUST00000025966.5
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr8_+_22155813 | 3.95 |
ENSMUST00000075268.5
|
Defa34
|
defensin, alpha, 34 |
chr3_+_129630380 | 3.91 |
ENSMUST00000077918.7
|
Cfi
|
complement component factor i |
chr5_+_115061293 | 3.87 |
ENSMUST00000031540.11
ENSMUST00000112143.4 |
Oasl1
|
2'-5' oligoadenylate synthetase-like 1 |
chrX_-_99638466 | 3.87 |
ENSMUST00000053373.2
|
P2ry4
|
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
chr1_-_82746169 | 3.85 |
ENSMUST00000027331.3
|
Tm4sf20
|
transmembrane 4 L six family member 20 |
chr4_-_61592331 | 3.79 |
ENSMUST00000098040.4
|
Mup18
|
major urinary protein 18 |
chr9_-_51240201 | 3.73 |
ENSMUST00000039959.11
ENSMUST00000238450.3 |
1810046K07Rik
|
RIKEN cDNA 1810046K07 gene |
chr3_-_88455556 | 3.72 |
ENSMUST00000131775.2
ENSMUST00000008745.13 |
Rab25
|
RAB25, member RAS oncogene family |
chr3_-_92672367 | 3.72 |
ENSMUST00000051521.5
|
Lce1h
|
late cornified envelope 1H |
chr13_-_42001102 | 3.66 |
ENSMUST00000121404.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr9_+_7692087 | 3.64 |
ENSMUST00000018767.8
|
Mmp7
|
matrix metallopeptidase 7 |
chr11_+_76792977 | 3.64 |
ENSMUST00000102495.8
|
Tmigd1
|
transmembrane and immunoglobulin domain containing 1 |
chr6_+_41331039 | 3.63 |
ENSMUST00000072103.7
|
Try10
|
trypsin 10 |
chr6_-_69584812 | 3.58 |
ENSMUST00000103359.3
|
Igkv4-55
|
immunoglobulin kappa variable 4-55 |
chr8_-_41668182 | 3.55 |
ENSMUST00000034003.5
|
Fgl1
|
fibrinogen-like protein 1 |
chr19_-_4548602 | 3.55 |
ENSMUST00000048482.8
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr3_+_132335575 | 3.52 |
ENSMUST00000212804.2
ENSMUST00000212852.2 |
Gimd1
|
GIMAP family P-loop NTPase domain containing 1 |
chrX_+_111404963 | 3.51 |
ENSMUST00000026602.9
ENSMUST00000113412.3 |
2010106E10Rik
|
RIKEN cDNA 2010106E10 gene |
chr2_+_15531281 | 3.51 |
ENSMUST00000146205.3
|
Malrd1
|
MAM and LDL receptor class A domain containing 1 |
chr11_-_116080361 | 3.49 |
ENSMUST00000148601.2
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr8_-_25066313 | 3.45 |
ENSMUST00000121992.2
|
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr13_-_63006176 | 3.44 |
ENSMUST00000021907.9
|
Fbp2
|
fructose bisphosphatase 2 |
chr9_+_5308828 | 3.44 |
ENSMUST00000162846.8
ENSMUST00000027012.14 |
Casp4
|
caspase 4, apoptosis-related cysteine peptidase |
chr11_-_73215442 | 3.43 |
ENSMUST00000021119.9
|
Aspa
|
aspartoacylase |
chr15_+_54975713 | 3.39 |
ENSMUST00000096433.10
|
Deptor
|
DEP domain containing MTOR-interacting protein |
chr3_-_73615732 | 3.37 |
ENSMUST00000029367.6
|
Bche
|
butyrylcholinesterase |
chr16_-_21814190 | 3.35 |
ENSMUST00000231766.2
ENSMUST00000074230.12 |
Liph
|
lipase, member H |
chr8_+_125302843 | 3.30 |
ENSMUST00000093033.6
ENSMUST00000133086.2 |
Capn9
|
calpain 9 |
chr7_-_25239229 | 3.29 |
ENSMUST00000044547.10
ENSMUST00000066503.14 ENSMUST00000064862.13 |
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr19_+_58717319 | 3.28 |
ENSMUST00000048644.6
ENSMUST00000236445.2 |
Pnliprp1
|
pancreatic lipase related protein 1 |
chr6_-_70318437 | 3.28 |
ENSMUST00000196599.2
|
Igkv8-19
|
immunoglobulin kappa variable 8-19 |
chr17_-_37200425 | 3.27 |
ENSMUST00000172711.2
|
Trim40
|
tripartite motif-containing 40 |
chr4_-_61259801 | 3.22 |
ENSMUST00000125461.8
|
Mup14
|
major urinary protein 14 |
chr2_+_57887896 | 3.20 |
ENSMUST00000112616.8
ENSMUST00000166729.2 |
Galnt5
|
polypeptide N-acetylgalactosaminyltransferase 5 |
chr8_-_94006345 | 3.19 |
ENSMUST00000034178.9
|
Ces1f
|
carboxylesterase 1F |
chr13_+_49697919 | 3.17 |
ENSMUST00000177948.2
ENSMUST00000021820.14 |
Aspn
|
asporin |
chr18_-_43925932 | 3.13 |
ENSMUST00000237926.2
ENSMUST00000096570.4 |
Gm94
|
predicted gene 94 |
chr13_-_42000958 | 3.12 |
ENSMUST00000072012.10
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr6_-_70194405 | 3.12 |
ENSMUST00000103384.2
|
Igkv8-24
|
immunoglobulin kappa chain variable 8-24 |
chr6_-_70121150 | 3.11 |
ENSMUST00000197525.2
|
Igkv8-28
|
immunoglobulin kappa variable 8-28 |
chr17_-_31363245 | 3.09 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr4_-_60618357 | 3.08 |
ENSMUST00000084544.5
ENSMUST00000098046.10 |
Mup11
|
major urinary protein 11 |
chr6_-_70383976 | 3.07 |
ENSMUST00000103393.2
|
Igkv6-15
|
immunoglobulin kappa variable 6-15 |
chr17_-_36501112 | 3.07 |
ENSMUST00000025312.13
ENSMUST00000102675.10 |
H2-T3
|
histocompatibility 2, T region locus 3 |
chr4_-_61357980 | 3.05 |
ENSMUST00000095049.5
|
Mup15
|
major urinary protein 15 |
chr7_-_98829474 | 3.02 |
ENSMUST00000207611.2
|
Dgat2
|
diacylglycerol O-acyltransferase 2 |
chr5_+_137979763 | 2.99 |
ENSMUST00000035390.7
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chr16_-_56533179 | 2.99 |
ENSMUST00000136394.8
|
Tfg
|
Trk-fused gene |
chr5_-_89583469 | 2.98 |
ENSMUST00000200534.2
|
Gc
|
vitamin D binding protein |
chr10_+_34359395 | 2.97 |
ENSMUST00000019913.15
|
Frk
|
fyn-related kinase |
chr11_-_21321144 | 2.95 |
ENSMUST00000060895.6
|
Ugp2
|
UDP-glucose pyrophosphorylase 2 |
chr13_+_23966524 | 2.94 |
ENSMUST00000074067.4
|
Trim38
|
tripartite motif-containing 38 |
chr3_-_146321341 | 2.93 |
ENSMUST00000200633.2
|
Dnase2b
|
deoxyribonuclease II beta |
chr4_-_60377932 | 2.90 |
ENSMUST00000107506.9
ENSMUST00000122381.8 ENSMUST00000118759.8 ENSMUST00000132829.3 |
Mup9
|
major urinary protein 9 |
chr17_-_26417982 | 2.90 |
ENSMUST00000142410.2
ENSMUST00000120333.8 ENSMUST00000039113.14 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr19_-_10952009 | 2.90 |
ENSMUST00000191343.7
|
Ms4a10
|
membrane-spanning 4-domains, subfamily A, member 10 |
chr15_-_77295234 | 2.88 |
ENSMUST00000089452.6
ENSMUST00000081776.11 |
Apol9a
|
apolipoprotein L 9a |
chr4_-_61514108 | 2.88 |
ENSMUST00000107484.2
|
Mup17
|
major urinary protein 17 |
chr5_-_100720063 | 2.88 |
ENSMUST00000031264.12
|
Plac8
|
placenta-specific 8 |
chr4_-_61184270 | 2.87 |
ENSMUST00000072678.6
ENSMUST00000098042.10 |
Mup13
|
major urinary protein 13 |
chr16_-_19226828 | 2.86 |
ENSMUST00000052516.5
ENSMUST00000206410.3 |
Olfr165
|
olfactory receptor 165 |
chr11_+_3939924 | 2.85 |
ENSMUST00000109981.2
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
chr6_-_69282389 | 2.84 |
ENSMUST00000103350.3
|
Igkv4-68
|
immunoglobulin kappa variable 4-68 |
chr10_+_116013256 | 2.84 |
ENSMUST00000155606.8
ENSMUST00000128399.2 |
Ptprr
|
protein tyrosine phosphatase, receptor type, R |
chr9_+_44951075 | 2.84 |
ENSMUST00000217097.2
|
Mpzl2
|
myelin protein zero-like 2 |
chr6_-_85846110 | 2.83 |
ENSMUST00000045008.8
|
Nat8f2
|
N-acetyltransferase 8 (GCN5-related) family member 2 |
chr4_-_61259997 | 2.83 |
ENSMUST00000071005.9
ENSMUST00000075206.12 |
Mup14
|
major urinary protein 14 |
chr2_+_162829250 | 2.83 |
ENSMUST00000018012.14
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr4_-_60538151 | 2.82 |
ENSMUST00000098047.3
|
Mup10
|
major urinary protein 10 |
chr12_-_103706774 | 2.80 |
ENSMUST00000186166.7
|
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr12_-_78953703 | 2.79 |
ENSMUST00000021544.8
|
Plek2
|
pleckstrin 2 |
chr2_-_24985161 | 2.78 |
ENSMUST00000044018.8
|
Noxa1
|
NADPH oxidase activator 1 |
chr4_-_60139857 | 2.75 |
ENSMUST00000107490.5
ENSMUST00000074700.9 |
Mup2
|
major urinary protein 2 |
chr6_-_67919524 | 2.74 |
ENSMUST00000196768.2
|
Igkv9-124
|
immunoglobulin kappa chain variable 9-124 |
chr4_-_63073028 | 2.72 |
ENSMUST00000142901.2
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr1_-_74343543 | 2.70 |
ENSMUST00000016309.16
|
Tmbim1
|
transmembrane BAX inhibitor motif containing 1 |
chr8_-_118398264 | 2.69 |
ENSMUST00000037955.14
|
Sdr42e1
|
short chain dehydrogenase/reductase family 42E, member 1 |
chr4_-_60070411 | 2.67 |
ENSMUST00000079697.10
ENSMUST00000125282.2 ENSMUST00000166098.8 |
Mup7
|
major urinary protein 7 |
chr4_-_61437704 | 2.65 |
ENSMUST00000095051.6
ENSMUST00000107483.8 |
Mup16
|
major urinary protein 16 |
chr15_-_63680596 | 2.64 |
ENSMUST00000110125.9
ENSMUST00000173503.3 |
Gsdmc
|
gasdermin C |
chr7_-_3680530 | 2.64 |
ENSMUST00000038743.15
|
Tmc4
|
transmembrane channel-like gene family 4 |
chr1_-_74344773 | 2.63 |
ENSMUST00000130763.8
|
Tmbim1
|
transmembrane BAX inhibitor motif containing 1 |
chr2_-_24985137 | 2.63 |
ENSMUST00000114373.8
|
Noxa1
|
NADPH oxidase activator 1 |
chr2_+_133394079 | 2.62 |
ENSMUST00000028836.7
|
Bmp2
|
bone morphogenetic protein 2 |
chr18_-_38342815 | 2.62 |
ENSMUST00000057185.13
|
Pcdh1
|
protocadherin 1 |
chr10_+_34359513 | 2.60 |
ENSMUST00000170771.3
|
Frk
|
fyn-related kinase |
chr6_-_70149254 | 2.59 |
ENSMUST00000197272.2
|
Igkv8-27
|
immunoglobulin kappa chain variable 8-27 |
chr7_+_34611804 | 2.59 |
ENSMUST00000075068.14
|
Pepd
|
peptidase D |
chr12_-_115276219 | 2.58 |
ENSMUST00000103529.4
|
Ighv1-58
|
immunoglobulin heavy variable 1-58 |
chr10_+_125802084 | 2.57 |
ENSMUST00000074807.8
|
Lrig3
|
leucine-rich repeats and immunoglobulin-like domains 3 |
chr19_+_30210320 | 2.57 |
ENSMUST00000025797.7
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr9_-_50466470 | 2.56 |
ENSMUST00000119103.2
|
Bco2
|
beta-carotene oxygenase 2 |
chr12_-_115832846 | 2.55 |
ENSMUST00000199373.2
|
Ighv1-78
|
immunoglobulin heavy variable 1-78 |
chr13_-_96607619 | 2.55 |
ENSMUST00000239026.2
ENSMUST00000181613.3 |
Ankdd1b
|
ankyrin repeat and death domain containing 1B |
chr3_-_73615535 | 2.52 |
ENSMUST00000138216.8
|
Bche
|
butyrylcholinesterase |
chr13_+_30320446 | 2.52 |
ENSMUST00000047311.16
|
Mboat1
|
membrane bound O-acyltransferase domain containing 1 |
chr6_-_70292451 | 2.52 |
ENSMUST00000103387.3
|
Igkv8-21
|
immunoglobulin kappa variable 8-21 |
chr14_-_70561231 | 2.51 |
ENSMUST00000151011.8
|
Slc39a14
|
solute carrier family 39 (zinc transporter), member 14 |
chr6_+_42222841 | 2.50 |
ENSMUST00000031897.8
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr11_+_69855584 | 2.50 |
ENSMUST00000108597.8
ENSMUST00000060651.6 ENSMUST00000108596.8 |
Cldn7
|
claudin 7 |
chr12_-_114140482 | 2.48 |
ENSMUST00000103475.2
ENSMUST00000195706.2 |
Ighv14-4
|
immunoglobulin heavy variable 14-4 |
chr1_-_130589349 | 2.48 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr2_-_20948230 | 2.47 |
ENSMUST00000140230.2
|
Arhgap21
|
Rho GTPase activating protein 21 |
chr5_-_143963413 | 2.47 |
ENSMUST00000031622.13
|
Ocm
|
oncomodulin |
chr1_-_130589321 | 2.44 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr16_-_45313324 | 2.42 |
ENSMUST00000114585.3
|
Gm609
|
predicted gene 609 |
chr6_+_68916540 | 2.40 |
ENSMUST00000103339.2
|
Igkv13-84
|
immunoglobulin kappa chain variable 13-84 |
chr4_-_61972348 | 2.40 |
ENSMUST00000074018.4
|
Mup20
|
major urinary protein 20 |
chrX_+_59044796 | 2.39 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr6_+_41279199 | 2.39 |
ENSMUST00000031913.5
|
Try4
|
trypsin 4 |
chr19_+_11724913 | 2.38 |
ENSMUST00000025585.4
|
Cblif
|
cobalamin binding intrinsic factor |
chr5_-_87288177 | 2.38 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr4_-_127222891 | 2.37 |
ENSMUST00000106091.9
|
Gjb3
|
gap junction protein, beta 3 |
chr7_+_25872836 | 2.33 |
ENSMUST00000082214.5
|
Cyp2b9
|
cytochrome P450, family 2, subfamily b, polypeptide 9 |
chr16_-_21814289 | 2.32 |
ENSMUST00000060673.8
|
Liph
|
lipase, member H |
chr15_-_97808502 | 2.32 |
ENSMUST00000173104.8
ENSMUST00000174633.8 |
Vdr
|
vitamin D (1,25-dihydroxyvitamin D3) receptor |
chr3_+_98187743 | 2.31 |
ENSMUST00000120541.8
ENSMUST00000090746.3 |
Hmgcs2
|
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
chr4_-_60777462 | 2.29 |
ENSMUST00000211875.2
|
Mup22
|
major urinary protein 22 |
chr18_-_31450095 | 2.29 |
ENSMUST00000139924.2
ENSMUST00000153060.8 |
Rit2
|
Ras-like without CAAX 2 |
chr6_-_69521891 | 2.28 |
ENSMUST00000103356.4
|
Igkv4-57-1
|
immunoglobulin kappa variable 4-57-1 |
chr13_+_91889626 | 2.26 |
ENSMUST00000022120.5
|
Acot12
|
acyl-CoA thioesterase 12 |
chr16_+_34815177 | 2.26 |
ENSMUST00000231589.2
|
Mylk
|
myosin, light polypeptide kinase |
chr2_+_162829422 | 2.26 |
ENSMUST00000117123.2
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr10_-_13744523 | 2.25 |
ENSMUST00000105534.10
|
Aig1
|
androgen-induced 1 |
chr6_+_70675416 | 2.25 |
ENSMUST00000103403.3
|
Igkv3-2
|
immunoglobulin kappa variable 3-2 |
chr3_+_92586546 | 2.24 |
ENSMUST00000047055.4
|
Lce1c
|
late cornified envelope 1C |
chr7_-_126975169 | 2.23 |
ENSMUST00000205832.2
|
Zfp747
|
zinc finger protein 747 |
chr4_-_108075119 | 2.23 |
ENSMUST00000223127.2
ENSMUST00000043793.7 ENSMUST00000106690.9 |
Zyg11a
|
zyg-11 family member A, cell cycle regulator |
chr5_-_143963461 | 2.23 |
ENSMUST00000110702.2
|
Ocm
|
oncomodulin |
chr1_-_164281344 | 2.22 |
ENSMUST00000193367.2
|
Atp1b1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr7_+_118196518 | 2.22 |
ENSMUST00000098088.11
ENSMUST00000121715.8 |
Tmc5
|
transmembrane channel-like gene family 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 4.0 | GO:0006711 | estrogen catabolic process(GO:0006711) |
1.8 | 7.3 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
1.7 | 5.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
1.7 | 10.0 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
1.6 | 4.9 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.4 | 5.5 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
1.3 | 5.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.3 | 5.0 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.3 | 7.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 3.6 | GO:0002780 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
1.2 | 3.5 | GO:0097037 | heme export(GO:0097037) |
1.2 | 7.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.2 | 2.3 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
1.1 | 3.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.0 | 3.0 | GO:0034201 | response to oleic acid(GO:0034201) |
1.0 | 5.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.0 | 3.9 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.9 | 4.7 | GO:1902336 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
0.9 | 3.6 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.9 | 4.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.9 | 3.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.9 | 2.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 10.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.8 | 2.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 6.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.7 | 2.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.7 | 2.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.7 | 2.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 2.0 | GO:2000077 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
0.7 | 22.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.7 | 2.6 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.6 | 4.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.6 | 3.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 3.2 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.6 | 1.9 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.6 | 3.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.6 | 5.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 3.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 3.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.6 | 4.7 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 1.7 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
0.6 | 1.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.6 | 1.2 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.6 | 3.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.6 | 1.7 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.6 | 1.7 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 5.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.5 | 1.6 | GO:0009087 | methionine catabolic process(GO:0009087) |
0.5 | 4.2 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.5 | 2.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 2.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 3.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 6.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.5 | 2.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.5 | 1.4 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.5 | 0.5 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.5 | 5.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 5.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 1.8 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.4 | 1.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 0.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.4 | 1.3 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.4 | 1.7 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.4 | 1.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 2.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.4 | 1.6 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.4 | 2.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 2.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.4 | 1.6 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.4 | 4.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 6.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.4 | 1.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 24.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 1.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 1.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 2.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.4 | 2.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.4 | 1.8 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.4 | 1.1 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.3 | 7.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 1.4 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.3 | 3.8 | GO:0015879 | carnitine transport(GO:0015879) |
0.3 | 1.0 | GO:0002632 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.3 | 1.7 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 4.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.3 | 1.0 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.3 | 1.0 | GO:0021629 | olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
0.3 | 1.3 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) response to selenium ion(GO:0010269) |
0.3 | 1.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 3.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 24.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 1.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.9 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.3 | 0.9 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) |
0.3 | 49.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 1.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 1.2 | GO:0010982 | GPI anchor release(GO:0006507) regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 3.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 1.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 1.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.3 | 1.2 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.3 | 0.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 1.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 5.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.3 | 0.8 | GO:1904432 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
0.3 | 0.5 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.3 | 0.8 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.3 | 1.3 | GO:0003409 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
0.3 | 0.8 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 5.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 1.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.3 | 1.0 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
0.3 | 1.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 1.0 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.3 | 2.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 2.7 | GO:0006569 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 1.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.2 | 2.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 1.4 | GO:0046618 | drug export(GO:0046618) |
0.2 | 3.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.7 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
0.2 | 1.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 1.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.7 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
0.2 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.7 | GO:0001812 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.7 | GO:0051036 | regulation of endosome size(GO:0051036) receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.4 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
0.2 | 6.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 1.3 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.2 | 0.6 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.2 | 4.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 1.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) growth involved in heart morphogenesis(GO:0003241) |
0.2 | 2.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.8 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 1.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.2 | 1.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.6 | GO:0006562 | proline catabolic process(GO:0006562) D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.2 | 0.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 3.2 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.2 | 3.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 2.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 2.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.2 | GO:0060197 | cloacal septation(GO:0060197) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
0.2 | 0.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.2 | 0.3 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.2 | 3.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 3.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 1.7 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.2 | 2.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 1.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:0048352 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.2 | 0.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 3.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.5 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.2 | 9.5 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.2 | 0.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 0.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.9 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.9 | GO:1901896 | protein localization to nuclear pore(GO:0090204) positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 1.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
0.1 | 19.9 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 2.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 1.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 2.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 3.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 1.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 1.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 2.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 1.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 2.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.8 | GO:0098734 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.1 | 2.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 16.0 | GO:0007586 | digestion(GO:0007586) |
0.1 | 1.1 | GO:0061709 | reticulophagy(GO:0061709) |
0.1 | 0.9 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.2 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.1 | 29.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 1.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 2.7 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 2.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 2.9 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 1.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.8 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 2.6 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 3.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 5.6 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.9 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.0 | GO:0061727 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 1.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.6 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.3 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.1 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 0.8 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.7 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 1.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 1.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 1.0 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.4 | GO:0045950 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
0.1 | 0.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.1 | 0.3 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 1.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 1.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 1.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.2 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 2.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 1.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 2.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.7 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.2 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 1.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 3.2 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.3 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.1 | 0.4 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
0.1 | 1.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 2.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 1.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 2.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.7 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 1.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 76.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 1.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 3.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0050822 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.1 | 0.4 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.9 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 1.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 2.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 4.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.2 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.3 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 4.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 2.9 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.5 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.6 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.4 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 4.7 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.4 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 3.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 11.9 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.0 | 2.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 2.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 10.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 1.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.5 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.4 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 1.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.2 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.0 | 0.2 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.0 | 0.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 1.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.0 | 0.1 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.0 | 0.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.0 | 0.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 1.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.9 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.7 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.0 | 1.4 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 1.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 1.0 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 3.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.0 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 1.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 1.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 1.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.0 | 1.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.5 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.6 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.0 | 1.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 2.1 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.2 | GO:0051683 | Golgi localization(GO:0051645) establishment of Golgi localization(GO:0051683) |
0.0 | 0.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.3 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.4 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0060133 | somatotropin secreting cell differentiation(GO:0060126) somatotropin secreting cell development(GO:0060133) |
0.0 | 2.1 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.0 | 0.3 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.9 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.0 | 0.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 0.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.5 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.6 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.6 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.0 | 0.4 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 1.3 | GO:0008033 | tRNA processing(GO:0008033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0061474 | phagolysosome membrane(GO:0061474) |
1.0 | 4.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 2.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.6 | 1.7 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.6 | 1.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.6 | 6.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.6 | 3.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 5.4 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 24.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 3.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.7 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.4 | 6.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 14.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 3.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 3.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 6.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 0.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.3 | 36.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 2.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 0.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 3.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.3 | 2.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 2.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.7 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
0.2 | 1.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.2 | 0.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.2 | 6.2 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 3.7 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 1.7 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.2 | 5.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 0.6 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.2 | 3.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.9 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.2 | 3.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 4.2 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 1.3 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 15.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 1.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 0.5 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.2 | 1.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 4.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 1.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 2.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 4.4 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 3.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 8.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 3.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0070992 | translation initiation complex(GO:0070992) |
0.1 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 2.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 2.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 9.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 2.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 6.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 4.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 10.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.0 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 3.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 1.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 10.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 11.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 5.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 2.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 77.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 14.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 4.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 7.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 4.9 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.8 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 20.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 6.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 109.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 26.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
2.4 | 9.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
2.0 | 8.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
2.0 | 5.9 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
1.7 | 6.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.5 | 4.5 | GO:0019807 | aspartoacylase activity(GO:0019807) |
1.5 | 7.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.3 | 5.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
1.3 | 3.9 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
1.2 | 4.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.2 | 4.7 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.1 | 3.4 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.8 | 5.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 13.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.8 | 3.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.8 | 5.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.8 | 2.3 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.8 | 3.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.7 | 2.2 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.7 | 23.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.7 | 5.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.7 | 1.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 2.7 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 2.0 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 4.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.7 | 2.0 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.7 | 2.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.7 | 2.0 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.6 | 1.9 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.6 | 1.9 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
0.6 | 3.6 | GO:0032810 | sterol response element binding(GO:0032810) |
0.6 | 3.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.6 | 2.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.6 | 4.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 1.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.5 | 1.5 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.5 | 3.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 5.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 0.9 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
0.4 | 1.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 2.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 2.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 5.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 4.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 1.6 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.4 | 1.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.4 | 1.6 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.4 | 11.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 1.1 | GO:0046911 | metal chelating activity(GO:0046911) |
0.4 | 2.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 4.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 1.1 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
0.4 | 4.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 1.7 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 14.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 3.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 2.6 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 5.7 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 1.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 1.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 1.2 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.3 | 0.9 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 2.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.3 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 1.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 5.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 2.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.3 | 5.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 8.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 36.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 1.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 5.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 4.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 8.0 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 1.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 3.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 1.0 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.2 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.7 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
0.2 | 1.8 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 2.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 2.1 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 6.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 1.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 4.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 1.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.6 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 2.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 15.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 2.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 4.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 2.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 3.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.3 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.8 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.2 | 1.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.6 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.6 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.4 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.1 | 4.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 3.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 1.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 2.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 1.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.4 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.1 | 0.7 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.8 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 3.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 1.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 3.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.5 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.7 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 2.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 7.4 | GO:0004620 | phospholipase activity(GO:0004620) |
0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 5.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 2.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 6.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 2.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 3.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 1.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 2.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.9 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.1 | 1.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 2.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 79.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 7.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.1 | 9.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 4.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 6.4 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.0 | 1.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 5.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.3 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 1.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 0.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 1.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 2.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 4.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 2.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.0 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 1.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 3.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.0 | 1.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 0.2 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.0 | 2.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.6 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 2.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 1.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 4.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 1.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 11.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 3.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 3.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 1.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 1.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 2.2 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.5 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 1.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 3.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 10.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 5.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 4.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 6.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 20.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 5.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 5.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 3.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 5.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 2.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 2.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 2.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.0 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 5.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 7.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 2.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 6.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 6.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 9.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 3.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 2.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 5.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 4.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 1.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 9.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 6.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 7.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 2.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 3.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 8.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 7.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 8.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 11.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 3.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 4.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 5.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 3.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 4.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 4.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 4.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 4.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 3.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 3.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 2.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 2.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |